Patent ID: 9539322
Date: 2017-01-10
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method for enhancing an antitumor T cell response and suppressing tumor growth in a tumor-bearing organism in need thereof, which comprises administering an anti-interleukin 6 (IL-6) receptor antibody and gemcitabine or a salt thereof to a tumor-bearing organism, wherein antitumor T cell response is enhanced and tumor growth is suppressed in the tumor-bearing organism in need thereof, and wherein the tumor-bearing organism has a cancer selected from the group consisting of stomach cancer, prostate cancer, head and neck cancer, breast cancer, lung cancer, colon cancer, and ovarian cancer, wherein the anti-IL-6 receptor antibody is a MR16-1 antibody or a PM-1 antibody.